Suppr超能文献

碘甲状腺原氨酸5'-脱碘酶的调节:体内和体外硫醇阻断剂及底物水平改变的影响

Regulation of iodothyronine 5'-deiodinases: effects of thiol blockers and altered substrate levels in vivo and in vitro.

作者信息

Goswami A, Rosenberg I N

机构信息

Department of Medicine, Framingham Union Hospital, Massachusetts 01701.

出版信息

Endocrinology. 1990 May;126(5):2597-606. doi: 10.1210/endo-126-5-2597.

Abstract

To study the physiological regulation of the iodothyronine 5'-deiodinases (I-5'D), we have examined the effects of some thiol blockers and of thyroid status on I-5'D activities both in vitro and in vivo. At low (less than 5 mM) concentrations of dithiothreitol, propylthiouracil (PTU) inhibited I-5'D in the brain, pituitary, and brown adipose tissue (BAT) of hypothyroid rats (which contain predominantly the type II activity); the patterns of inhibition in these tissues were essentially similar, with a Ki of about 174 microM at 250 microM dithiothreitol. Hydroxyethyldisulfide was a strong inhibitor of the type II enzyme, with relatively little effect on the renal enzyme at both high concentrations (micromolar) of T4, i.e. predominantly type I activity, and low concentrations (nanomolar) to T4, i.e. both type I and low Km activity. Preincubation of cerebral microsomes with PTU, followed by removal of excess PTU, resulted in 70% inhibition of I-5'D activity in cerebral microsomes at 5 mM dithiothreitol; the corresponding inhibitions of the renal enzyme at high and low substrate concentrations were 66% and 48%, respectively. Specific binding of PTU to renal and cerebral microsomes was diminished by hydroxyethyldisulfide, but not by T4, suggesting that PTU binding was not dependent on substrate interaction. Administration of PTU in vivo (1 mg/100 g BW, ip; 1 h before killing) resulted in approximately 80% inhibition of I-5'D activity in renal microsomes at high T4, and 50-70% inhibition in pituitary, BAT, and renal microsomes at low T4, but no inhibition was observed in brain microsomes. HPLC analyses revealed a PTU content of 35-65 nmol/g wet wt in the pituitary, BAT, liver, and kidney, but no PTU was detected in the brain, suggesting that PTU may be excluded by the blood-brain barrier. Maintaining hypothyroid rats on 1 microgram T4/100 g BW.day for 5 days enhanced renal type I and low Km I-5'D with restoration of serum T3 to normal levels, although the type II I-5'Ds from all sources were severely depressed. A supraphysiological dose of T4 depressed all three I-5'Ds. The data indicate that the I-5'Ds are regulated in a qualitatively similar fashion.

摘要

为研究碘甲状腺原氨酸5'-脱碘酶(I-5'D)的生理调节机制,我们在体外和体内研究了一些巯基阻断剂及甲状腺状态对I-5'D活性的影响。在低浓度(低于5 mM)二硫苏糖醇存在时,丙硫氧嘧啶(PTU)抑制甲状腺功能减退大鼠脑、垂体和棕色脂肪组织(BAT)中的I-5'D(这些组织主要含II型活性);这些组织中的抑制模式基本相似,在250 microM二硫苏糖醇时Ki约为174 microM。羟乙基二硫化物是II型酶的强抑制剂,在高浓度(微摩尔)T4(即主要为I型活性)和低浓度(纳摩尔)T4(即I型和低Km活性)时对肾酶的影响相对较小。脑微粒体与PTU预孵育,然后去除过量PTU,在5 mM二硫苏糖醇时导致脑微粒体中I-5'D活性抑制70%;在高底物浓度和低底物浓度时肾酶的相应抑制率分别为66%和48%。羟乙基二硫化物可降低PTU与肾和脑微粒体的特异性结合,但T4无此作用,提示PTU结合不依赖于底物相互作用。体内给予PTU(1 mg/100 g体重,腹腔注射;处死前1小时)导致高T4时肾微粒体中I-5'D活性抑制约80%,低T4时垂体、BAT和肾微粒体中抑制50 - 70%,但脑微粒体中未观察到抑制。HPLC分析显示垂体、BAT、肝脏和肾脏中PTU含量为35 - 65 nmol/g湿重,但脑中未检测到PTU,提示PTU可能被血脑屏障排除。甲状腺功能减退大鼠以1微克T4/100 g体重·天维持5天可增强肾I型和低Km I-5'D,同时血清T3恢复至正常水平,尽管所有来源的II型I-5'D均严重受抑。超生理剂量的T4可抑制所有三种I-5'D。数据表明I-5'D以定性相似的方式受到调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验